The Journal of Immunology, Vol 147, Issue 6 1786-1791, Copyright © 1991 by American Association of Immunologists

ARTICLES

The generation of immunogenic peptides can be selectively increased or decreased by proteolytic enzyme inhibitors

L Vidard, KL Rock and B Benacerraf
Institut Curie Unite d'Immunogenetique CNRS URA 1413 75231 Paris, France.

The ability of splenic APC and a B cell hybridoma (LS.102.9) to process and present OVA to a panel of T-T hybridomas with different fine specificities was investigated. Splenic APC process and present OVA to all the T-T hybrids. The B cell hybridoma could similarly process and present OVA to some T-T hybrids but was very inefficient in stimulating two of the T cell hybridomas. The presentation of native OVA to these two T-T hybrids was significantly increased by leupeptin. Pulsing experiments demonstrated that leupeptin acted on the APC at a step before the processed Ag was displayed on the cell surface in association with MHC molecules. Leupeptin has no effect on the presentation of OVA peptides by LS.102.9 to the T-T hybrids. Leupeptin inhibits the generation of the epitopes of OVA that LS.102.9 produces under basal conditions. We also surveyed the effect of other protease inhibitors and observed similar augmenting and inhibitory effects on the presentation of selected OVA epitopes. The augmentation of processing by a protease inhibitor indicates that in the lysosomal/endosomal compartment proteases have capacity to both generate and destroy immunogenic peptides. Our data suggest that protease inhibitors could potentially be used as immunomodulators and are discussed in terms of physiology of the lysosomal/endosomal compartment.

This article has been cited by other articles:

				K. T. Hastings, R. L. Lackman, and P. Cresswell Functional Requirements for the Lysosomal Thiol Reductase GILT in MHC Class II-Restricted Antigen Processing J. Immunol., December 15, 2006; 177(12): 8569 - 8577. [Abstract] [Full Text] [PDF]

				L. Delamarre, R. Couture, I. Mellman, and E. S. Trombetta Enhancing immunogenicity by limiting susceptibility to lysosomal proteolysis J. Exp. Med., September 4, 2006; 203(9): 2049 - 2055. [Abstract] [Full Text] [PDF]

				A. Schonemeyer, R. Lucius, B. Sonnenburg, N. Brattig, R. Sabat, K. Schilling, J. Bradley, and S. Hartmann Modulation of Human T Cell Responses and Macrophage Functions by Onchocystatin, a Secreted Protein of the Filarial Nematode Onchocerca volvulus J. Immunol., September 15, 2001; 167(6): 3207 - 3215. [Abstract] [Full Text] [PDF]

				M. Khalil, K. Inaba, R. Steinman, J. Ravetch, and B. Diamond T Cell Studies in a Peptide-Induced Model of Systemic Lupus Erythematosus J. Immunol., February 1, 2001; 166(3): 1667 - 1674. [Abstract] [Full Text] [PDF]

				R. M. Syme, J. C. L. Spurrell, L. L. Ma, F. H. Y. Green, and C. H. Mody Phagocytosis and Protein Processing Are Required for Presentation of Cryptococcus neoformans Mitogen to T Lymphocytes Infect. Immun., November 1, 2000; 68(11): 6147 - 6153. [Abstract] [Full Text] [PDF]

				D. M. Fernandes, A. M. Baird, L. J. Berg, and K. L. Rock A Monoclonal Antibody Reactive with a 40-kDa Molecule on Fetal Thymocytes and Tumor Cells Blocks Proliferation and Stimulates Aggregation and Apoptosis J. Immunol., August 1, 1999; 163(3): 1306 - 1314. [Abstract] [Full Text] [PDF]

				H. Reijonen, J. F. Elliott, P. van Endert, and G. Nepom Differential Presentation of Glutamic Acid Decarboxylase 65 (GAD65) T Cell Epitopes Among HLA-DRB1*0401-Positive Individuals J. Immunol., August 1, 1999; 163(3): 1674 - 1681. [Abstract] [Full Text] [PDF]

				J. Deussing, W. Roth, P. Saftig, C. Peters, H. L. Ploegh, and J. A. Villadangos Cathepsins B and D are dispensable for major histocompatibility complex class II-mediated antigen presentation PNAS, April 14, 1998; 95(8): 4516 - 4521. [Abstract] [Full Text] [PDF]

				J. A. Villadangos, R. J. Riese, C. Peters, H. A. Chapman, and H. L. Ploegh Degradation of Mouse Invariant Chain: Roles of Cathepsins S and D and the Influence of Major Histocompatibility Complex Polymorphism J. Exp. Med., August 18, 1997; 186(4): 549 - 560. [Abstract] [Full Text] [PDF]